Baidu
map

妇幼专科医院高警示药品安全管理与使用专家共识

2020-08-30 药学服务与研究.2020.20(4):255-260.

目的:针对妇幼专科医院的用药特点,建立与妇幼专科医院药品管理相契合的高警示药品目录、管理制度、使用规范及高警示药品统一标识。方法:收集全国16家妇幼专科医院现有的高警示药品目录、管理制度、使用规范及标

中文标题:

妇幼专科医院高警示药品安全管理与使用专家共识

发布机构:

发布日期:

2020-08-30

简要介绍:

目的:针对妇幼专科医院的用药特点,建立与妇幼专科医院药品管理相契合的高警示药品目录、管理制度、使用规范及高警示药品统一标识。方法:收集全国16家妇幼专科医院现有的高警示药品目录、管理制度、使用规范及标识,中国妇幼保健协会药事管理专业委员会组织专家应用德尔菲法建立药品遴选标准,筛选出具体的高警示药品,然后进行分类、汇总,确定统一的妇幼专科医院高警示药品目录,同时建立高警示药品管理制度、使用规范及统一标识。结果和结论:建立了妇幼专科医院高警示药品安全管理与使用专家共识,起草了适用于妇幼专科医院高警示药品的管理制度、使用规范及统一标识,可以从各个环节加强高警示药品的管理,使之更符合妇幼专科医院药品管理的实际,有助于降低妇幼专科医院用药风险,减少药源性伤害。

相关资料下载:
[AttachmentFileName(sort=1, fileName=妇幼专科医院高警示药品安全管理与使用专家共识_张海.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4efdd1c001982e8b, title=妇幼专科医院高警示药品安全管理与使用专家共识, enTitle=, guiderFrom=药学服务与研究.2020.20(4):255-260., authorId=0, author=, summary=目的:针对妇幼专科医院的用药特点,建立与妇幼专科医院药品管理相契合的高警示药品目录、管理制度、使用规范及高警示药品统一标识。方法:收集全国16家妇幼专科医院现有的高警示药品目录、管理制度、使用规范及标, cover=https://img.medsci.cn/2020930/1601478674210_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun Aug 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>目的:针对妇幼专科医院的用药特点,建立与妇幼专科医院药品管理相契合的高警示药品目录、管理制度、使用规范及高警示药品统一标识。方法:收集全国16家妇幼专科医院现有的高警示药品目录、管理制度、使用规范及标识,中国妇幼保健协会药事管理专业委员会组织专家应用德尔菲法建立药品遴选标准,筛选出具体的高警示药品,然后进行分类、汇总,确定统一的妇幼专科医院高警示药品目录,同时建立高警示药品管理制度、使用规范及统一标识。结果和结论:建立了妇幼专科医院高警示药品安全管理与使用专家共识,起草了适用于妇幼专科医院高警示药品的管理制度、使用规范及统一标识,可以从各个环节加强高警示药品的管理,使之更符合妇幼专科医院药品管理的实际,有助于降低妇幼专科医院用药风险,减少药源性伤害。</p> </div> </div> </div>, tagList=[TagDto(tagId=55848, tagName=妇幼)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=55848, guiderKeyword=妇幼, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2725, appHits=96, showAppHits=0, pcHits=659, showPcHits=2628, likes=2, shares=10, comments=8, approvalStatus=1, publishedTime=Wed Sep 30 23:43:29 CST 2020, publishedTimeString=2020-08-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 30 23:11:22 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 01:51:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=妇幼专科医院高警示药品安全管理与使用专家共识_张海.pdf)])
妇幼专科医院高警示药品安全管理与使用专家共识_张海.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=976021, encodeId=20629e602198, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/07/b8560605399fc9659527b2bdad0d28ef.jpg, createdBy=2f125274374, createdName=药师汪, createdTime=Wed Jun 23 07:19:08 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904500, encodeId=13a2904500f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:37:03 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893861, encodeId=f4748938612a, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=1931, createdTime=Thu Oct 22 22:48:20 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893857, encodeId=746d89385e00, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=14672af5m09暂无昵称, createdTime=Thu Oct 22 22:41:20 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892457, encodeId=465789245e63, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=14672af5m09暂无昵称, createdTime=Fri Oct 16 14:39:48 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2021-06-23 药师汪

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=976021, encodeId=20629e602198, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/07/b8560605399fc9659527b2bdad0d28ef.jpg, createdBy=2f125274374, createdName=药师汪, createdTime=Wed Jun 23 07:19:08 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904500, encodeId=13a2904500f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:37:03 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893861, encodeId=f4748938612a, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=1931, createdTime=Thu Oct 22 22:48:20 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893857, encodeId=746d89385e00, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=14672af5m09暂无昵称, createdTime=Thu Oct 22 22:41:20 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892457, encodeId=465789245e63, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=14672af5m09暂无昵称, createdTime=Fri Oct 16 14:39:48 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-12-03 12544b9em05暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=976021, encodeId=20629e602198, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/07/b8560605399fc9659527b2bdad0d28ef.jpg, createdBy=2f125274374, createdName=药师汪, createdTime=Wed Jun 23 07:19:08 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904500, encodeId=13a2904500f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:37:03 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893861, encodeId=f4748938612a, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=1931, createdTime=Thu Oct 22 22:48:20 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893857, encodeId=746d89385e00, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=14672af5m09暂无昵称, createdTime=Thu Oct 22 22:41:20 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892457, encodeId=465789245e63, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=14672af5m09暂无昵称, createdTime=Fri Oct 16 14:39:48 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-10-22 1931

    👍👍

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=976021, encodeId=20629e602198, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/07/b8560605399fc9659527b2bdad0d28ef.jpg, createdBy=2f125274374, createdName=药师汪, createdTime=Wed Jun 23 07:19:08 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904500, encodeId=13a2904500f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:37:03 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893861, encodeId=f4748938612a, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=1931, createdTime=Thu Oct 22 22:48:20 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893857, encodeId=746d89385e00, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=14672af5m09暂无昵称, createdTime=Thu Oct 22 22:41:20 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892457, encodeId=465789245e63, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=14672af5m09暂无昵称, createdTime=Fri Oct 16 14:39:48 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-10-22 14672af5m09暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=976021, encodeId=20629e602198, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/07/b8560605399fc9659527b2bdad0d28ef.jpg, createdBy=2f125274374, createdName=药师汪, createdTime=Wed Jun 23 07:19:08 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904500, encodeId=13a2904500f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:37:03 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893861, encodeId=f4748938612a, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=1931, createdTime=Thu Oct 22 22:48:20 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893857, encodeId=746d89385e00, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=14672af5m09暂无昵称, createdTime=Thu Oct 22 22:41:20 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892457, encodeId=465789245e63, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/201a0bf1c8774775920c4db17c2a4ddb/0a8d2c62e4cb4d58b3ecbc9c2ed8b2f9.jpg, createdBy=62f95139558, createdName=14672af5m09暂无昵称, createdTime=Fri Oct 16 14:39:48 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-10-16 14672af5m09暂无昵称

    👍

    0

Baidu
map
Baidu
map
Baidu
map